COVID-19 in a Leukemic Child

Muhd Alwi Muhd Helmi; Fahisham Taib; Nik Khairulddin Nik Yusof; Ariffin  Nasir; Norsarwany Mohamad

doi:10.51407/mjpch.v27i1.119

Authors

Muhd Alwi Muhd Helmi Department of Peadiatric, Kulliyyah of Medicine, Internatioanl Islamic University Malaysia
Fahisham Taib Department of Pediatrics, School of Medical Sciences, Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan, Malaysia
Nik Khairulddin Nik Yusof Hospital Raja Perempuan Zainab II, (Paediatric Department), Kota Bharu, (Kelantan), Malaysia
Ariffin Nasir Department of Pediatrics, School of Medical Sciences, Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan, Malaysia
Norsarwany Mohamad Department of Pediatrics, School of Medical Sciences, Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan, Malaysia

DOI:

https://doi.org/10.51407/mjpch.v27i1.119

Keywords:

COVID-19, SARS-CoV-2, Immunocompromised

Abstract

The newly emerged SARS-CoV-2 Betacoronavirus strain has infected more than one million people worldwide. The COVID-19 infection in children was reported to be less severe compared to adults. At this point, there were limited data available to describe the effect of COVID-19 infection in immunocompromised children. We reported a case of SARS-CoV-2 infection in an immunocompromised child with a delayed virus clearance. The report signifies the variability in the severity of SARS-CoV-2 infection in immunocompromised children together with a prolonged period of viral clearance.

Downloads

Download data is not yet available.

References

Zimmermann P, Curtis N. Coronavirus infections in children including COVID-19: an overview of the epidemiology, clinical features, diagnosis, treatment and prevention options in children. The Pediatric infectious disease journal. 2020 May;39(5):355.

Haleemunnissa S, Didel S, Swami MK, Singh K, Vyas V. Children and COVID19: understanding impact on the growth trajectory of an evolving generation. children and youth services review. 2020 Nov 28;105754.

CodeBlue. Covid-19 Infected 3,000 Babies, Children In Sabah. 2020 20 November 2020 [cited 2020 2 December 2020]; Available from: https://codeblue.galencentre.org/2020/11/20/covid-19-infected-3000-babies-children-in-sabah/.

Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, Tong S. Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China. Pediatrics. 2020 Mar 1.

Ogimi C, Englund JA, Bradford MC, Qin X, Boeckh M, Waghmare A. Characteristics and outcomes of coronavirus infection in children: the role of viral factors and an immunocompromised state. Journal of the Pediatric Infectious Diseases Society. 2019 Mar;8(1):21-8.

Fishman JA, Grossi PA. Novel Coronavirus-19 (COVID-19) in the immunocompromised transplant recipient: #Flatteningthecurve. Am J Transplant. 2020 Jul;20(7):1765-1767. doi: 10.1111/ajt.15890.

Akbari H, Tabrizi R, Lankarani KB, Aria H, Vakili S, Asadian F, Noroozi S, Keshavarz P, Faramarz S. The role of cytokine profile and lymphocyte subsets in the severity of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis. Life sciences. 2020 Jul 29;118167.

Okyay R, Sahin A, Aguinada R, Tasdogan M. Why are Children Less Affected by COVID-19 ? Could there be an Overlooked Bacterial Co-Infection?. EJMO. 2020; 4(1): 104-105. doi: 10.14744/ejmo.2020.40743

Chen Z, Xiong H, Li JX, Li H, Tao F, Yang YT, Wu B, Tang W, Teng JX, Fu Q, Yang L. COVID-19 with post-chemotherapy agranulocytosis in childhood acute leukemia: a case report. Zhonghua xue ye xue za zhi= Zhonghua xueyexue zazhi. 2020 Apr 1;41(4):341-3.

D'Antiga L. Coronaviruses and Immunosuppressed Patients: The Facts During the Third Epidemic. Liver Transpl. 2020 Jun;26(6):832-834. doi: 10.1002/lt.25756.

Babaha F, Rezaei N. Primary Immunodeficiency Diseases in COVID-19 Pandemic: A Predisposing or Protective Factor? Am J Med Sci. 2020 Dec;360(6):740-741. doi: 10.1016/j.amjms.2020.07.027.

Zhang Q, Bastard P, Liu Z, Le Pen J, Moncada-Velez M, Chen J, Ogishi M, Sabli IK, Hodeib S, Korol C, Rosain J. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science. 2020 Oct 23;370(6515).

Quinti I, Lougaris V, Milito C, Cinetto F, Pecoraro A, Mezzaroma I, Mastroianni CM, Turriziani O, Bondioni MP, Filippini M, Soresina A, Spadaro G, Agostini C, Carsetti R, Plebani A. A possible role for B cells in COVID-19? Lesson from patients with agammaglobulinemia. J Allergy Clin Immunol. 2020 Jul;146(1):211-213.e4. doi: 10.1016/j.jaci.2020.04.013.

Qiu H, Wu J, Hong L, Luo Y, Song Q, Chen D. Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study. Lancet Infect Dis. 2020 Jun;20(6):689-696. doi: 10.1016/S1473-3099(20)30198-5.

Brooks SK, Webster RK, Smith LE, Woodland L, Wessely S, Greenberg N, Rubin GJ. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet. 2020 Mar 14;395(10227):912-920. doi: 10.1016/S0140-6736(20)30460-8.